Oxford Biomedica (OXB) RNS Announcements

Add to Alert list
Date Time Source Announcement
16 May 2005 07:00 AM
RNS
Phase II trials of TroVax
12 May 2005 04:00 PM
RNS
Holding(s) in Company
12 May 2005 10:24 AM
RNS
2005 ASCO Annual Meeting
10 May 2005 12:05 PM
RNS
AGM Statement
09 May 2005 07:00 AM
RNS
European Patent Granted
05 May 2005 07:00 AM
RNS
Preclinical Effiancy Data
27 Apr 2005 04:00 PM
RNS
Holding(s) in Company
22 Apr 2005 03:03 PM
RNS
Holding(s) in Company
20 Apr 2005 04:41 PM
RNS
Holding(s) in Company
15 Apr 2005 03:49 PM
RNS
Holding(s) in Company
29 Mar 2005 07:00 AM
RNS
Notice of AGM
29 Mar 2005 07:00 AM
RNS
Notice of Allowance
22 Mar 2005 11:42 AM
RNS
Director Shareholding
21 Mar 2005 07:00 AM
RNS
Final Results
14 Mar 2005 12:47 PM
RNS
LentiVector Technology
10 Mar 2005 07:00 AM
RNS
Presenting at SG Cowen Conf
04 Mar 2005 09:25 AM
RNS
Directorate Change
04 Mar 2005 07:00 AM
RNS
Notice of Results
02 Mar 2005 07:00 AM
RNS
Results from 3 Phase II Trial
01 Mar 2005 12:17 PM
RNS
Holding(s) in Company
17 Feb 2005 01:54 PM
RNS
Progress Report
07 Feb 2005 07:00 AM
RNS
Offer Talks Terminated
01 Feb 2005 07:00 AM
RNS
Licensing Agreement
31 Jan 2005 09:18 AM
RNS
Holding(s) in Company
28 Jan 2005 07:00 AM
RNS
Rule 2.10 Announcement
27 Jan 2005 07:00 AM
RNS
Rule 2.10 Announcement
26 Jan 2005 05:39 PM
RNS
Holding(s) in Company
21 Jan 2005 11:26 AM
RNS
Holding(s) in Company
21 Jan 2005 07:00 AM
RNS
Rule 2.10 Announcement
20 Jan 2005 07:00 AM
RNS
Rule 2.10 Announcement
19 Jan 2005 07:00 AM
RNS
Stmnt re Share Price Movement
12 Jan 2005 07:00 AM
RNS
Holding(s) in Company
05 Jan 2005 07:00 AM
RNS
Agreement with Biogen Idec
16 Dec 2004 07:00 AM
RNS
New Preclinical Data
13 Dec 2004 07:00 AM
RNS
Licence Agreement
19 Nov 2004 02:15 PM
RNS
Blocklisting Interim Review
01 Nov 2004 04:00 PM
RNS
Holding(s) in Company
29 Oct 2004 07:00 AM
RNS
Extended Collaboration
12 Oct 2004 10:37 AM
RNS
Director Shareholding
01 Oct 2004 06:06 PM
RNS
Holding(s) in Company
22 Sep 2004 04:00 PM
RNS
Holding(s) in Company
17 Sep 2004 04:06 PM
RNS
Holding(s) in Company
17 Sep 2004 07:00 AM
RNS
License Agreement
02 Sep 2004 04:30 PM
RNS
Holding(s) in Company
01 Sep 2004 07:01 AM
RNS
TroVax Phase II Trials
01 Sep 2004 07:00 AM
RNS
Interim Results
24 Aug 2004 09:24 AM
RNS
Notice of WebCast
18 Aug 2004 07:00 AM
RNS
Appointment of Broker
15 Jul 2004 04:30 PM
RNS
Holding(s) in Company
06 Jul 2004 04:30 PM
RNS
Holding(s) in Company

Oxford Biomedica is a company that specialises in cell and gene therapy, and is a leader in the development of gene-based medicines. They work with pharmaceutical and biotechnology companies to develop and manufacture viral vectors, including lentivirus, adeno-associated virus, and adenoviral vectors.

Headquartered in Oxford, Oxford Biomedica has manufacturing facilities in Oxfordshire, UK, Lyon and Strasbourg, France, and near Boston, MA, US.

Oxford Biomedica share price listed in London under the ticker OXB at 2,570p.

UK 100

Latest directors dealings